Herbas VPB

Print
EN | LT
LT - SEL DE METFORMINE D`ELAFIBRANOR PRESENTANT UNE ACTIVITE DUALE POUR LE TRAITEMENT DE L`OBESITE ASSOCIEE A LA STEATO-HEPATITE NON ALCOOLIQUE (NASH) ET A L`HYPERTRIGLYCERIDEMIE
EN - DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/155
A61K 31/192
C07C 279/26
C07C 323/62
A61K 9/00
A61P 1/16
A61P 3/06
A61P 3/10
A61P 3/04
A61P 9/00
European patent
(11) Number of the document 3518912
(13) Kind of document T
(96) European patent application number 17781051.2
Date of filing the European patent application 2017-09-28
(97) Date of publication of the European application 2019-08-07
(45) Date of publication and mention of the grant of the patent 2020-12-30
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2017/074703
Date 2017-09-28
PCT application publication
(87) Number WO 2018/060373
Date 2018-04-05
Priority applications
(30) Number Date Country code
1659435 2016-09-30 FR
Inventors
(72)
LARUELLE, Claude, FR
BONNAFOUS, Ludovic, FR
Grantee
(73) Nashpharm, 18 avenue Bellevue, 06270 Villeneuve Loubet, FR
Title
(54) SEL DE METFORMINE D`ELAFIBRANOR PRESENTANT UNE ACTIVITE DUALE POUR LE TRAITEMENT DE L`OBESITE ASSOCIEE A LA STEATO-HEPATITE NON ALCOOLIQUE (NASH) ET A L`HYPERTRIGLYCERIDEMIE
  DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA